基于运动的心脏康复在稳定性胸痛中:关于当前证据和潜在的生理机制的叙述性综述
Joyce M Heutinck1,2, Iris A de Koning3, Tom Vromen4
1Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, The Netherlands. joyce.heutinck@radboudumc.nl.
概括
稳定性胸痛 (SAP) 管理可能受益于基于运动的心脏康复. 这种方法针对全身炎症和血管功能障碍,为重血管化提供了一个有希望的替代方案.
科学领域:
- 心脏病学 心脏病学
- 预防性心脏病学 预防性心脏病学
- 运动生理学 运动生理学
背景情况:
- 稳定性胸痛 (SAP) 给健康带来了巨大的负担,目前还在讨论是否需要再血管化以及最佳的医疗治疗.
- 目前的治疗重点是局部病变,但SAP的根本原因是系统性动脉样硬化和广泛的血管功能障碍.
- 心血管事件源于斑块负担和高风险特征,而不仅仅是阻塞性病变.
研究的目的:
- 探索稳定性胸痛 (SAP) 的替代治疗策略,超出传统的复血管化.
- 评估以运动为基础的心脏康复 (EBCR) 作为SAP的潜在一线治疗.
- 检查生理机制和证据支持EBCR在管理SAP时.
主要方法:
- 本综述综合了SAP中EBCR生理机制的现有证据.
- 它分析了EBCR在解决系统性炎症和血管功能障碍方面的作用.
- 该综述总结了目前关于EBCR在SAP患者疗效的研究结果.
主要成果:
- 重血管化针对的是局部问题,而SAP则是系统性炎症状况.
- EBCR提供一种生理学方法,针对整个心血管系统.
- 作为SAP的有效一线治疗方法,EBCR显示出希望.
结论:
- 基于运动的心脏康复 (EBCR) 是一种可行的,生理治疗方法,用于稳定性胸痛 (SAP).
- 通过向全身血管功能障碍和炎症,EBCR可能会改善生活质量.
- 进一步研究EBCR作为SAP的主要治疗方法是有必要的.
更多相关视频
00:07Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
Published on: August 24, 2019
9.7K
12:45Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
10.5K
相关概念视频
01:20Exercise and Cardiovascular Response
826
Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
826
01:17Exercise and Cardiac Output
1.1K
Regular physical activity is essential for maintaining cardiovascular health, with aerobic exercises being particularly effective. According to the American Heart Association, 150 minutes of moderate to intense aerobic exercise per week is recommended for a healthy heart. Aerobic activities may include brisk walking, running, bicycling, cross-country skiing, and swimming, ideally performed three to five times per week.
Sustained exercise increases the muscles' oxygen demand, which can be...
Sustained exercise increases the muscles' oxygen demand, which can be...
1.1K
01:26Exercise Stress Test
236
Introduction
Exercise stress testing, commonly known as a treadmill test, is a noninvasive procedure used to evaluate cardiovascular function and diagnose heart conditions.
Definition
An exercise stress test measures the heart's response to exertion using a treadmill or stationary bicycle. Chest electrodes record the heart's electrical activity through an ECG, and blood pressure is monitored regularly.
Purposes
Exercise stress testing, commonly known as a treadmill test, is a noninvasive procedure used to evaluate cardiovascular function and diagnose heart conditions.
Definition
An exercise stress test measures the heart's response to exertion using a treadmill or stationary bicycle. Chest electrodes record the heart's electrical activity through an ECG, and blood pressure is monitored regularly.
Purposes
236
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
436
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
436
01:22Heart Failure Drugs: β-Blockers
344
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
344
01:25Antianginal Drugs: Calcium Channel Blockers and Ranolazine
538
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
538